|Year : 2021 | Volume
| Issue : 4 | Page : 481-484
Monocanalicular intubation in children with incomplete complex congenital nasolacrimal duct obstruction older than five years of age
Bahram Eshraghi, Mansooreh Jamshidian Tehrani, Fereshteh Tayebi, Bita Momenaei
Department of Plastic and Reconstructive Surgery, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
|Date of Submission||10-Feb-2021|
|Date of Decision||01-Aug-2021|
|Date of Acceptance||03-Aug-2021|
|Date of Web Publication||06-Jan-2022|
Mansooreh Jamshidian Tehrani
Department of Plastic and Reconstructive Surgery, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran
Source of Support: None, Conflict of Interest: None
Purpose: To evaluate the role of monocanalicular intubation (MCI) in congenital nasolacrimal duct obstruction (CNLDO) in children older than 5 years of age.
Methods: A retrospective case series study was done on children over 5 years of age diagnosed with CNLDO who underwent MCI. Success rates were evaluated subjectively by asking their parents about persistent symptoms and objectively using the dye disappearance test in clinical examination.
Results: A total of 43 eyes of 37 patients with a mean age of 7.42 ± 2.33 (range, 5–15 years of age) were included. The success rate was 60.46%, and the rate of secondary surgical intervention was 25% of all cases (61.11% of failed cases).
Conclusion: Primary MCI maintains a reasonable success rate in incomplete complicated CNLDO regardless of age.
Keywords: Age over 5 years old, Congenital nasolacrimal duct obstruction, Crawford intubation, Monocanalicular intubation
|How to cite this article:|
Eshraghi B, Jamshidian Tehrani M, Tayebi F, Momenaei B. Monocanalicular intubation in children with incomplete complex congenital nasolacrimal duct obstruction older than five years of age. J Curr Ophthalmol 2021;33:481-4
|How to cite this URL:|
Eshraghi B, Jamshidian Tehrani M, Tayebi F, Momenaei B. Monocanalicular intubation in children with incomplete complex congenital nasolacrimal duct obstruction older than five years of age. J Curr Ophthalmol [serial online] 2021 [cited 2022 Jan 17];33:481-4. Available from: http://www.jcurrophthalmol.org/text.asp?2021/33/4/481/335037
| Introduction|| |
One of the most common orbital problems in children is congenital nasolacrimal duct obstruction (CNLDO)., Approximately 20%–30% of all newborn infants present with CNLDO symptoms. The rate of spontaneous resolution in infants up to 1-year-old age is about 96%. Management of CNLDO in the 1st year of life is usually conservative with hydrostatic massage and topical antibiotics., In cases of unresolved epiphora beyond the age of 1-year, probing is the procedure of choice with high success rates.,,, In a small minority of children with failed probing or older children as a primary intervention, silicon tube intubation is preferred by many ophthalmologists.,, One of the most popular techniques for silicone tube intubation is monocanalicular intubation (MCI) which is simple and less traumatic than bicanalicular intubation.
Indeed, many surgeons believe that probing alone does not have an acceptable success rate in children older than 2 years of age,, because fibrosis and inflammation persist in these cases. Furthermore, in another hypothesis, more complex obstructions accumulate with time. However, some researchers claim that there is no decrease in the probing success rate in older children. Probing is a safe procedure that is easy to perform and more convenient for both the surgeon and the child in comparison to more invasive approaches like balloon dacryoplasty and dacryocystorhinostomy. Besides that, in our literature review, there has been no age limit for performing dacryocystorhinostomy in children till now.
Hence, the management of CNLDO in older children is controversial, and there is a lack of consensus on the approach for first intervention, especially in ages older than 5 years, which is the target age group in this study.
| Methods|| |
This is a retrospective case series study done in Farabi Eye Hospital of Tehran and a private eye hospital in Isfahan on patients diagnosed with CNLDO with ages of 5–15 years old, between 2009 and 2017, who underwent probing and MCI. Tehran University of Medical Sciences' Ethical Board Committee approved the protocol (Ethics approval code: 9511257014) and informed consents were obtained. Tenets of the Declaration of Helsinki were followed. Medical records were reviewed. Under general anesthesia, all patients underwent irrigation tests, and CNLDO was approved. Then inferior punctum was dilated, and Bowman's probe (number 0 or 00) was used for probing, and patency was confirmed with metal on metal touching, using a Crawford hook. According to the surgeon's diagnosis based on probing at the time of surgery, patients with an incomplete complex type of obstruction were included. It was considered when the probe could reach the nasal cavity with some effort, and there were multiple sites of nasolacrimal obstructions (tactile sensation) without any bony resistance or very narrow nasolacrimal duct in which smaller size of the probe and/or more force was needed to pass through. A medium collarette Monoka tube attached to a Fayet-Bernard metal probe (FCI, Paris, France) was inserted in the lower canalicular system and fixed in the punctum in 37 patients, and Masterka tube (FCI-Ophthalmics, Marshfield Hills, MA) was used in 6 patients by pushing the tube into the nasolacrimal duct. Then the introducer was removed, and the tube was anchored in place at the punctum by a plug-like fixation head. Topical fluorometholone 0.1% (FML) and chloramphenicol 0.5% were instilled every 6 h for the first 10 postoperative days. The tube was removed after 2 months. Two oculoplastic surgeons did all surgeries.
Patients with histories of previous trauma to the lacrimal system, surgical procedures on the lacrimal drainage system, punctal or canalicular abnormalities, complete complex nasolacrimal duct obstruction, craniofacial anomalies, and nasal pathology were excluded.
We visited the patients after 1 week, and 3, and 12 months. The dye disappearance test was done as an objective test for evaluating the procedure's success. It was considered negative (dye disappearance test grade 0–1) if it disappeared or there was faint dye in the tear film after 3 min. We also asked about persistent epiphora or purulent discharge as a subjective symptom of failed cases or any other secondary surgical interventions needed for treating these cases.
The resolution was defined as not having epiphora or purulent discharge for 12 months following surgery, and a negative dye disappearance test and MUNK score of 0 or 1. Descriptive statistics is used in the dataset. The chart of demographic information, including age, sex, success, and the failure rate of surgical intervention, and the need for secondary intervention were reviewed.
| Results|| |
In this study, we included 43 eyes of 37 patients diagnosed with CNLDO. The mean age of patients was 7.42 ± 2.33 (ranging from 5 to 15 years of age). Twenty-four patients (64.86%) were male. No patient had a previous history of probing. Fourteen eyes (31.81%) were correct, and 17 eyes (39.53%) were left eyes, and six patients (13.63%) had bilateral involvement. The demographic data of each subgroup (successful and failed cases) are mentioned in [Table 1].
Six eyes underwent Masterka intubation, and the rest (37 eyes) underwent Monoka Crawford intubation. The mean follow-up time was 12.4 ± 0.6 months.
In 26 eyes (60.46%), there was no tearing and purulent discharge up to 12 months after tube removal, and a successful dye disappearance test, which is defined as a success rate.
Eleven (25%) of all eyes (61.11% of failed cases) underwent secondary surgical intervention. Other failed cases did not come to follow-up exams. Finally, dacryocystorhinostomy was done for four eyes, and balloon dacryoplasty for five eyes and two eyes underwent reintubation according to the surgeon's decision. The final success rate for initially failed cases who underwent additional surgery was 63.63%.
| Discussion|| |
This study reports success rates of probing monocanalicular silicone intubation in CNLDO in children over the age of 5 years as the first line of surgical intervention. CNLDO is divided into two subgroups. Simple forms are defined as a single distal membranous block at the Hasner valve that can be overcome in the absence of resistance or without much resistance., Complex forms consist of any nasolacrimal duct variations, a firm bony obstruction, impacted inferior turbinate, nondevelopment of nasolacrimal duct, or those associated with craniofacial abnormalities or syndromes. These complex types are also in the forms of complete (firm bony resistance preventing the probe from reaching the nasal cavity and repeated probing did not alter the condition) and incomplete (included narrow bone canal and multiple mucosal stenosis).,
MCI is a simple treatment done by many ophthalmologists in children older than 1 year who did not respond to conservative management. As children grow up, simple obstructions tend to cure, and more complex ones remain, and it is why the success rate of treatment options decreases by increasing age. Dacryocystorhinostomy is reserved as the last option in persistent nasolacrimal duct obstruction in children., However, in our literature review, there was no cut-off for age to perform dacryocystorhinostomy in CNLDO cases.
In a study by Kashkouli et al., initial nasolacrimal duct probing is advised for up to 5 years. Andalib et al. reported the same result for bicanalicular versus MCI in children with CNLDO (89% vs. 86.2%, respectively). Eshraghi et al., in another study, found that bicanalicular intubation in incomplete complex CNLDO had a higher success rate in comparison to MCI, although the difference was not significant (74.4% vs. 59.6%). In many previous types of research, age is considered a risk factor of probing success rate,, although the others did not have such results.,,,
In a study by Eshraghi et al., 53.3% of children older than 18 months with incomplete complex NLDO resolved thoroughly after Masterka intubation. In a study by Okumuş et al., 73.3% of children ranging from 7 to 15 years complete resolved during the follow-up period (8.8 ± 3.4 months). In a systematic review, Tai et al. mentioned that age is not predictive of intubation failure up to approximately 10 years old, which agrees with our results.
In this study, we included children over 5 years of age who were all in the incomplete complex type according to probing at the time of surgery, and Crawford intubation was done for them with a success rate of 60.46%, which is a similar rate of success in comparison to the previously mentioned study. As mentioned previously, MCI is easier to perform and less traumatic to the lacrimal system and has a lower rate of complications in comparison to bicanalicular intubation. Another advantage of MCI is that removal is simply done in the office.
Indeed, we think that as the pathophysiology of CNLDO is known and the same in all different age groups, our approach is also the same regardless of age and includes the following: Probing is first done. If the obstruction is simple (the probe reaches nasal cavity with ease after popping sensation), it is sufficient. However, if it is incomplete complex, we can insert a Monoka Crawford tube, and in incomplete complex cases, dacryocystorhinostomy should be done. Hence, it is crucial to identify the type of obstruction while we are doing probing, and it is better to complete the procedure in one session according to the kind of obstruction.
The effectiveness of probing reduces with age because more severe obstructions remain after the initial high rates of spontaneous opening, and age is not supposed to have the central role in deciding about which surgical procedure should be done in CNLDO cases with attention to the similar pathophysiology. Clinicians must consider the type of obstruction (simple, incomplete complex, complete complex) to choose the best surgical intervention modality for each child regardless of his/her age.
This study has several limitations. The sample size was small, and the follow-up time was relatively short.
According to our study, ophthalmologists should keep probing and intubation in mind as an initial surgical option for treating children with CNLDO regardless of age before performing more complicated procedures such as early dacryocystorhinostomy. Nevertheless, to find the actual effect of age, we need to research comparing simple CNLDO of different age groups who underwent probing and also incomplete complex forms of various ages who underwent Crawford intubation.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ceylan K, Yuksel D, Duman S, Samim E. Comparison of two endoscopically assisted procedures in primary surgical treatment of congenital nasolacrimal duct obstruction in children older than 3 years: Balloon dilatation and bicanalicular silicone tube intubation. Int J Pediatr Otorhinolaryngol 2007;71:11-7.
Takahashi Y, Kakizaki H, Chan WO, Selva D. Management of congenital nasolacrimal duct obstruction. Acta Ophthalmol 2010;88:506-13.
Eshraghi B, Akbari MR, Fard MA, Shahsanaei A, Assari R, Mirmohammadsadeghi A. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction. Graefes Arch Clin Exp Ophthalmol 2014;252:1847-52.
Kashkouli MB, Beigi B, Parvaresh MM, Kassaee A, Tabatabaee Z. Late and very late initial probing for congenital nasolacrimal duct obstruction: What is the cause of failure? Br J Ophthalmol 2003;87:1151-3.
Kapadia MK, Freitag SK, Woog JJ. Evaluation and management of congenital nasolacrimal duct obstruction. Otolaryngol Clin North Am 2006;39:959-77.
Eshraghi B, Khalilipour E, Ameli K, Bazvand F, Mirmohammadsadeghi A. Pushed monocanalicular intubation versus probing for the treatment of simple and incomplete complex types of congenital nasolacrimal duct obstruction in children older than 18 months old. Orbit 2017;36:218-22.
Aggarwal RK, Misson GP, Donaldson I, Willshaw HE. The role of nasolacrimal intubation in the management of childhood epiphora. Eye (Lond) 1993;7:760-2.
Kassoff J, Meyer DR. Early office-based vs late hospital-based nasolacrimal duct probing. A clinical decision analysis. Arch Ophthalmol 1995;113:1168-71.
Repka MX, Chandler DL, Holmes JM, Hoover DL, Morse CL, Schloff S, et al.
Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing. Arch Ophthalmol 2009;127:633-9.
Eshraghi B, Jamshidian-Tehrani M, Mirmohammadsadeghi A. Comparison of the success rate between monocanalicular and bicanalicular intubations in incomplete complex congenital nasolacrimal duct obstruction. Orbit 2017;36:215-7.
Rajabi MT, Zavarzadeh N, Mahmoudi A, Johari MK, Hosseini SS, Abrishami Y, et al.
Bicanalicular versus monocanalicular intubation after failed probing in congenital nasolacrimal duct obstruction. Int J Ophthalmol 2016;9:1466-70.
Pe MR, Langford JD, Linberg JV, Schwartz TL, Sondhi N. Ritleng intubation system for treatment of congenital nasolacrimal duct obstruction. Arch Ophthalmol 1998;116:387-91.
Lee H, Ahn J, Lee JM, Park M, Baek S. Clinical effectiveness of monocanalicular and bicanalicular silicone intubation for congenital nasolacrimal duct obstruction. J Craniofac Surg 2012;23:1010-4.
Rajabi MT, Abrishami Y, Hosseini SS, Tabatabaee SZ, Rajabi MB, Hurwitz JJ. Success rate of late primary probing in congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 2014;51:360-2.
Yüksel D, Ceylan K, Erden O, Kiliç R, Duman S. Balloon dilatation for treatment of congenital nasolacrimal duct obstruction. Eur J Ophthalmol 2005;15:179-85.
Eshragi B, Fard MA, Masomian B, Akbari M. Probing for congenital nasolacrimal duct obstruction in older children. Middle East Afr J Ophthalmol 2013;20:349-52.
] [Full text]
Robb RM. Success rates of nasolacrimal duct probing at time intervals after 1 year of age. Ophthalmology 1998;105:1307-9.
MacEwen CJ, Young JD. The Fluorescein Disappearance Test (FDT): An evaluation of its use in infants. J Pediatr Ophthalmol Strabismus 1991;28:302-5.
Munk PL, Lin DT, Morris DC. Epiphora: Treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage apparatus. Radiology 1990;177:687-90.
Khatib L, Nazemzadeh M, Revere K, Katowitz WR, Katowitz JA. Use of the Masterka for complex nasolacrimal duct obstruction in children. J AAPOS 2017;21:380-3.
Kashkouli MB, Abtahi MB, Sianati H, Mahvidizadeh N, Pakdel F, Kashkouli PB, et al.
A novel one-stage obstruction-based endoscopic approach to congenital nasolacrimal duct obstruction. Ophthalmic Plast Reconstr Surg 2017;33:350-4.
Ali MJ, Kamal S, Gupta A, Ali MH, Naik MN. Simple vs complex congenital nasolacrimal duct obstructions: Etiology, management and outcomes. Int Forum Allergy Rhinol 2015;5:174-7.
Saeed BM, Tawalbeh M. Pediatric endoscopic DCR: The outcome in 50 patients. Indian J Otolaryngol Head Neck Surg 2014;66:276-80.
Bothra N, Wani RM, Ganguly A, Tripathy D, Rath S. Primary nonendoscopic endonasal versus external dacryocystorhinostomy in nasolacrimal duct obstruction in children. Indian J Ophthalmol 2017;65:1004-7.
] [Full text]
Kashkouli MB, Kassaee A, Tabatabaee Z. Initial nasolacrimal duct probing in children under age 5: Cure rate and factors affecting success. J AAPOS 2002;6:360-3.
Andalib D, Gharabaghi D, Nabai R, Abbaszadeh M. Monocanalicular versus bicanalicular silicone intubation for congenital nasolacrimal duct obstruction. J AAPOS 2010;14:421-4.
Al-Faky YH, Al-Sobaie N, Mousa A, Al-Odan H, Al-Huthail R, Osman E, et al.
Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction. J AAPOS 2012;16:53-7.
Mannor GE, Rose GE, Frimpong-Ansah K, Ezra E. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction. Am J Ophthalmol 1999;127:616-7.
Zwaan J. Treatment of congenital nasolacrimal duct obstruction before and after the age of 1 year. Ophthalmic Surg Lasers 1997;28:932-6.
Pediatric Eye Disease Investigator Group; Repka MX, Chandler DL, Beck RW, Crouch ER 3rd
, Donahue S, et al.
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology 2008;115:577-84.e3.
Al-Faky YH, Mousa A, Kalantan H, Al-Otaibi A, Alodan H, Alsuhaibani AH. A prospective, randomised comparison of probing versus bicanalicular silastic intubation for congenital nasolacrimal duct obstruction. Br J Ophthalmol 2015;99:246-50.
Okumuş S, Öner V, Durucu C, Coşkun E, Aksoy Ü, Durucu E, et al.
Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children. Eye (Lond) 2016;30:85-8.
Tai EL, Kueh YC, Abdullah B. The use of stents in children with nasolacrimal duct obstruction requiring surgical intervention: A systematic review. Int J Environ Res Public Health 2020;17:1067.